Ellis Libby, Woods Laura M, Estève Jacques, Eloranta Sandra, Coleman Michel P, Rachet Bernard
Cancer Research UK Cancer Survival Group, London School of Hygiene and Tropical Medicine, London, United Kingdom.
Int J Cancer. 2014 Oct 15;135(8):1774-82. doi: 10.1002/ijc.28990. Epub 2014 Jun 19.
Cancer incidence, survival and mortality are essential population-based indicators for public health and cancer control. Confusion and misunderstanding still surround the estimation and interpretation of these indicators. Recurring controversies over the use and misuse of population-based cancer statistics in health policy suggests the need for further clarification. In our article, we describe the concepts that underlie the measures of incidence, survival and mortality, and illustrate the synergy between these measures of the cancer burden. We demonstrate the relationships between trends in incidence, survival and mortality, using real data for cancers of the lung and breast from England and Sweden. Finally, we discuss the importance of using all three measures in combination when interpreting overall progress in cancer control, and we offer some recommendations for their use.
癌症发病率、生存率和死亡率是基于人群的公共卫生和癌症控制的重要指标。对于这些指标的估计和解释仍然存在混淆和误解。在卫生政策中,关于基于人群的癌症统计数据的使用和滥用问题反复出现争议,这表明需要进一步澄清。在我们的文章中,我们描述了发病率、生存率和死亡率测量背后的概念,并说明了这些癌症负担测量指标之间的协同作用。我们利用英格兰和瑞典肺癌和乳腺癌的实际数据,展示了发病率、生存率和死亡率趋势之间的关系。最后,我们讨论了在解释癌症控制的总体进展时综合使用这三个指标的重要性,并给出了一些使用建议。